Tagged with EG

Mexico Representatives of Olivares, one of the leading law firms in Mexico, explain the evolving status of cannabis and narcotics for medicinal use in the country. A new Bill authorizing the use of cannabis for medical treatments was passed by the Senate in December 2016, but there is still a long…

Greece  Astellas Greece & Cyprus MD, Harry Nardis, emphasizes the importance of integrity, compliance and innovation to the Astellas business model, key priorities, navigating the Greek pharmaceutical landscape while maintaining a high-quality reputation, and retaining the company’s vision of being at the forefront of healthcare change. Having assumed the leadership position…

Switzerland Patient-driven drug pricing, the uncertain future of Switzerland’s tax regime, and new business models for life science innovators in a changing global market are just a few of the topics touched upon by KPMG Switzerland’s head of life sciences Martin Rohrbach. On February 12th the Swiss people rejected the Tax…

Greece “There is nothing so stable as change” says chairman of the medical devices and diagnostics committee for the American Chamber of Commerce and GM for J&J Medical Hellas, Theodore Liakopoulos. Having spearheaded the affiliate through the economic crisis, Liakopoulos speaks candidly about his strategic priorities, the importance of staying agile to…

Mexico Enrique Carballido, general manager Mexico and Latin South America at Bio-Rad, showcases Bio-Rad’s offering in both diagnostics and life sciences and the crucial role of the entire industry in helping public health institutions more effectively allocate their resources based on the number of patients covered and the economical savings obtained.…

Greece Michalis Massourakis, Chief Economist at the Federation of Greek Industries (SEV) provides his expert insights on the roles and functions of the organization, the economic and political situation in Greece, and how the country is managing to implement policies to boost the economy and transition out of the crisis. To…

Mexico Gent Hoxha, founder and CEO of lab equipment specialist Aspelab, explains the company’s growth strategy in Mexico, the intricacies of the Mexican medtech market, and how Aspelab’s solutions enhance both the quality of life of patients and the efficiency of laboratories. Could you please introduce our international audience to the…

Greece After an extensive career in pharma spanning multiple geographies, Roche’s Managing Director for Greece, Anne Nijs, is now tackling the Herculean challenge of the Greek pharmaceutical landscape. She speaks about Roche’s focus on bringing differentiated innovation to market, the holistic approach of the organization amidst the crisis, as well as…

Mexico Victor Casasola, CEO at Canitec, explains the unique business model of his Mexican medical devices success story, offering an integral service to its clients, and showcases the high added value and quality of its broad portfolio of laboratory equipment. Could you please introduce to our international audience the key activities…

Switzerland Recently arrived from Germany, ALK’s new general manager for Switzerland highlights some of the unique features of the Swiss allergology field, and some of the opportunities for ALK to positively impact patients’ lives in the future.   ALK says roughly one in five people suffer from some degree of allergy…

Greece Stavros Theodorakis, managing director of Chiesi Greece & Cyprus and vice president of the Hellenic Association of Pharmaceutical Companies (SFEE), pinpoints the factors that successfully carried the company through the Greek crisis, while highlighting co-branding and co-promotion as the key strategies behind Chiesi’s leading position in the domestic respiratory market.…

Mexico Fausto Hernández, CEO at ValidPro, explains the unique business model of the company as well as the high added value of its qualification and validation services; offering integral solution that position ValidPro as the regulatory partner of choice for the pharmaceutical industry. Could you please introduce yourself to our international…